Hims & Hers Health, Inc. HIMS
29.42
0.14
0.48%
as of 25 Sep
- Market cap
- $6.9B
- P/E
- 0.0×
Follow HIMS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
94.53 | 56.96 | 0.00 | 0.00 |
P/S ratio |
5.81 | 3.11 | 2.00 | 3.12 | |
P/FCF ratio |
95.88 | 98.76 | 59.47 | 96.77 | |
P/Operating CF |
86.33 | 119.14 | 53.05 | (223.56) | |
P/B ratio |
22.10 | 13.50 | 10.63 | 24.79 | |
Price to Tangible BV |
101.24 | 109.86 | 0.00 | 0.00 | |
EV/Sales |
5.96 | 3.28 | 2.09 | 3.32 | |
EV/EBITDA |
83.39 | 47.35 | 118.84 | 0.00 | |
EV/Operating CF |
40.54 | 25.66 | 17.71 | 32.49 | |
EV/FCF |
98.43 | 104.10 | 62.27 | 103.09 | |
Quick Ratio |
1.40 | 1.51 | 1.46 | 0.82 | |
Current Ratio |
1.88 | 1.90 | 1.69 | 0.93 | |
Net Debt/EBITDA |
11.41 | 13.96 | (4.08) | (7.97) | |
Debt/Assets |
43.48% | 45.14% | 42.97% | 37.62% | |
Debt/Equity |
1.67 | 1.80 | 2.18 | 4.21 | |
Asset Turnover |
1.56 | 1.64 | 1.50 | 0.94 | |
Operating CF/Net income |
9.43 | 2.98 | (0.97) | 0.42 | |
Capex/Depreciation |
(3.61) | (3.11) | (1.26) | (0.82) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6.77% | 6.63% | 7.72% | 7.29% | |
Selling, General and Administrative Expense of Revenue |
52.23% | 50.86% | 54.54% | 56.77% | |
Intangible Assets out of Total Assets |
0.20 | 0.22 | 0.27 | 0.42 | |
Share Based Compensation of Revenue |
6.71% | 5.58% | 6.06% | 5.59% | |
Graham Net Nets |
(0.06) | (0.12) | (0.16) | (0.24) | |
Graham Number |
5.89 | 5.55 | 0.00 | 0.00 | |
Earnings Yield |
1.06% | 1.76% | (0.24%) | (1.76%) | |
Free Cash Flow Yield |
1.04% | 1.01% | 1.68% | 1.03% | |
Revenue per Share |
2.65 | 2.75 | 2.66 | 3.25 | |
Operating CF per Share |
0.66 | 0.27 | 0.39 | (0.16) | |
Capex per Share |
(0.29) | (0.26) | (0.13) | (0.11) | |
Free Cash Flow per Share |
0.37 | 0.01 | 0.26 | (0.27) | |
Cash per Share |
2.78 | 2.57 | 3.29 | 3.63 | |
Shareholders Equity per Share |
2.57 | 2.40 | 1.95 | 1.40 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.57 | 2.40 | 1.95 | 1.40 | |
Free Cash Flow |
83.46 | 1.92 | 59.51 | (61.86) | |
Working Capital |
394.48 | 363.21 | 426.59 | (98.62) | |
Capital Expenditures |
(65.26) | (59.39) | (29.84) | (25.93) | |
Net Current Asset Value |
(807.06) | (846.14) | (775.51) | (1,920.13) | |
EV/EBIT |
114.58 | 72.90 | 0.00 | 0.00 | |
Capex to Sales |
0.11 | 0.10 | 0.05 | 0.03 | |
Net Profit Margin |
2.63% | 3.33% | (15.15%) | (11.46%) | |
Price to Operating Income |
111.62 | 69.16 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 17.69 | 77.05 | 189.60 | |
Average Payables |
136.93 | 117.23 | 207.89 | 303.15 | |
Average Inventory |
77.55 | 72.28 | 77.58 | 114.79 | |
Average Assets |
1,417.78 | 1,431.12 | 1,579.38 | 2,753.20 | |
Average Common Equity |
510.52 | 508.82 | 497.71 | 443.38 |
Columns are period end dates